George Coukos, MD, PhD

Highlights

1
Nature · 2024
GCGeorge Coukos
PMID: 38658764PMCID: PMC11078736DOISenior author212 citations
2
Cancer discovery · 2021
GCGeorge Coukos
PMID: 34479871PMCID: PMC9401506DOISenior author453 citations
3
Cell reports · 2021
GCGeorge Coukos
PMID: 34289354PMCID: PMC8371260DOISenior author108 citations

416

Completed grants (7)

PI
Transformative personalized vascular disrupting cancer immunotherapy
NCI · 2010–2016 · via NIH RePORTER
R01CA156695-05
PI
Phase I/II Randomized Tiral of Adoptive Lymphocyte Transfer in Ovarian Cancer
NIH · 2008–2016 · via NIH RePORTER
R01FD003520-04
PI
Administrative Core
NCI · 2009–2015 · via NIH RePORTER
P50CA083638-15
PI
COMPLEMENT IN CANCER ESTABLISHMENT AND GROWTH
NIAID · 2007–2013 · via NIH RePORTER
P01AI068730-05
PI
Vaccine-Dac/Bev Combinatorial Therapy in Ovarian Cancer
NCI · 2011–2013 · via NIH RePORTER
R21CA156224-02
PI
Vascular Leukocytes Induce regulatory T cells (Treg) in Tumors
NCI · 2006–2011 · via NIH RePORTER
R01CA116779-05
PI
Endothelial Regulation of T Cell Homing in Ovarian Carcinoma
NCI · 2003–2009 · via NIH RePORTER
R01CA098951-05

New Laboratory to Advance Personalized, Cell-Based Cancer Therapies
February 4, 2026
Dr. George Coukos, an internationally renowned expert on cancer immunology, is launching the Ludwig Laboratory for Cell Therapy at Weill Cornell Medicine.

Ludwig Institute for Cancer Research